Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Tallac Therapeutics

    Client Virtual Booth

    TALLAC THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Tallac Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    866 Malcolm Road Suite 100, Burlingame, CA 94010
    Telephone
    Telephone
    (650) 866-1966
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.tallactherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/tallac-therapeutics/
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Tallac Therapeutics Presents TAC-001 Preclinical Data at AACR
    Tallac Therapeutics Presents TAC-001 Preclinical Data at AACR

    https://www.businesswire.com/news/home/20240410584376/en

    BUSINESSWIRE
    10 Apr 2024
    Share Share
    Tallac Presents First Clinical Data for TAC-001 at SITC 2023
    Tallac Presents First Clinical Data for TAC-001 at SITC 2023

    https://www.businesswire.com/news/home/20231103234375/en

    BUSINESSWIRE
    03 Nov 2023
    Share Share
    Tallac Therapeutics Announces Two Abstracts Accepted for Presentation
    Tallac Therapeutics Announces Two Abstracts Accepted for Presentation

    https://www.businesswire.com/news/home/20230927484960/en

    BUSINESSWIRE
    27 Sep 2023
    Share Share
    Tallac Therapeutics Appoints Kevin N. Heller, M.D., as Chief Medical Officer
    Tallac Therapeutics Appoints Kevin N. Heller, M.D., as Chief Medical Officer

    https://www.businesswire.com/news/home/20230119005166/en

    BUSINESSWIRE
    19 Jan 2023
    Share Share
    Tallac Presents Data for Two, First-in-Class Toll-like Receptor 9 Agonist
    Tallac Presents Data for Two, First-in-Class Toll-like Receptor 9 Agonist

    https://www.businesswire.com/news/home/20221111005048/en

    BUSINESSWIRE
    12 Nov 2022
    Share Share
    Tallac Therapeutics Announces First Patient Dosed with TAC-001
    Tallac Therapeutics Announces First Patient Dosed with TAC-001

    https://www.businesswire.com/news/home/20220728005280/en

    BUSINESSWIRE
    28 Jul 2022
    Share Share
    Tallac Therapeutics Announces FDA Clearance of IND Application for TAC-001
    Tallac Therapeutics Announces FDA Clearance of IND Application for TAC-001

    https://www.businesswire.com/news/home/20220519005790/en

    BUSINESSWIRE
    19 May 2022
    Share Share
    Selexis and Tallac Therapeutics Collaborate to Advance Tallac’s Pipeline
    Selexis and Tallac Therapeutics Collaborate to Advance Tallac’s Pipeline

    https://www.businesswire.com/news/home/20210323005232/en

    BUSINESSWIRE
    23 Mar 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search